Informing Hospital Formulary Decisions in China: A Multi-Criteria Value Framework for GLP-1 Receptor Agonists
This study fills the gap in clinical evaluation research on GLP-1RA drugs in China. The proposed evaluation system provides scientific support for hospital pharmaceutical management, medical insurance inclusion, and drug procurement, promoting value-based hospital drug selection strategies.
Authors
- Haiyin Wang (ORCID: https://orcid.org/0000-0001-9560-0460)
- Xia Xu (ORCID: https://orcid.org/0009-0006-9104-8123)
- Dan Qin
- Sitong Lin
- Yuancheng Jiang
Institutions
- China Pharmaceutical University (CN)
- Kunming Medical University (CN)
- Shanghai Medical Information Center (CN)
Publication Details
- Journal
- Risk Management and Healthcare Policy
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/rmhp.s564791
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00